Nurse Practitioner in Nyc, NY Accepting Medicare

8 Nurse Practitioner nurses found. Showing 1 - 8

Vanessa Dutchin, NP Nurse Practitioner - Adult Health Medicare: Medicare Enrolled Practice Location: 560 First Ave, Th 183, Nyc, NY 10016 Phone: 212-263-7411

Rebecca Jo White, RN, PNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 460 W 41st St, Covenant House Under 21, Nyc, NY 10036 Phone: 212-613-0315    Fax: 212-268-2832

Ms. Holly Joy Snyder, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 622 West 168th Street, Columbia University, Ph 4-476, Nyc, NY 10032 Phone: 212-305-5020

Ms. Maryellen Wyllie, NP Nurse Practitioner - Adult Health Medicare: Not Enrolled in Medicare Practice Location: Ny Presbyterian Hospital Family Planning Clinic, 21 Audobon Avenue, Nyc, NY 10032 Phone: 212-342-3211

Ms. Sandra Infantino, NP Nurse Practitioner - Women's Health Medicare: Medicare Enrolled Practice Location: 21 Audobon Avenue, Ny Presbyterian Hospital, Family Planning Clinic, Nyc, NY 10032 Phone: 212-342-3225    Fax: 212-342-3238

Victoria Curtin, WHNP-C Nurse Practitioner - Women's Health Medicare: Not Enrolled in Medicare Practice Location: Seventh Avenue@27th St Rm A402, Fashion Institute Of Technology, Nyc, NY 10001 Phone: 212-217-4190    Fax: 212-217-4191

Ms. Sharyn Smith Tondel, RN,NP-C Nurse Practitioner - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 517 East 71 St, Nyc, NY 10021 Phone: 212-606-1389    Fax: 212-774-2904

Mrs. Ester Anunciado Bautro, RN,MA,ACNP,CCRN Nurse Practitioner - Primary Care Medicare: Not Enrolled in Medicare Practice Location: Fifth Avenue & 100 St, Mount Sinai Medical Center, Nyc, NY 10029 Phone: 212-241-4844    Fax: 212-241-9353

News Archive

C4 Imaging receives FDA clearance for Sirius MRI Marker

C4 Imaging LLC is pleased to announce U.S. Food and Drug Administration 510(k) clearance of its first product, the Sirius™ MRI Marker. The novel Positive-Signal MRI Marker will be used following treatment of prostate cancer with brachytherapy to facilitate seed localization within the prostate, utilizing a single post-implant Magnetic Resonance imaging procedure.

Impact of type I interferon (IFN) autoantibodies in critical COVID-19

A new preprint discusses the pathogenesis of this critical COVID-19 with reference to autoimmune phenomena involving the key antiviral type I interferon pathway.

PARP-1 plays a major role in controlling AR function in prostate cancer patients

A newly discovered function of PARP-1 could be the key to more effective therapeutics to treat advanced prostate cancer patients, a recent preclinical study published in Cancer Discovery by Jefferson's Kimmel Cancer Center researchers suggests.

Ryogen licenses gene patent to Invitrogen

Ryogen LLC announced today that the company have entered into a nonexclusive license agreement with Invitrogen Corporation, whereby Invitrogen has licensed from Ryogen the patent directed to the clinically important Aminopeptidase P gene.

Read more Medical News

› Verified 2 days ago